| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Major Pharmaceuticals | 20260313 | 5 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20260312 | 7 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Laurus Labs Limited | 20260112 | 4 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Strides Pharma Science Limited | 20260105 | 8 |
| Lamivudine Oral Solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Chartwell Govermental & Specialty RX, LLC. | 20260102 | 2 |
| LAMIVUDINE oral solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Chartwell RX, LLC | 20251230 | 3 |
| LAMIVUDINE TABLETS. These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Golden State Medical Supply, Inc. | 20251124 | 9 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Merck Sharp & Dohme LLC | 20251029 | 23 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | ViiV Healthcare Company | 20251029 | 19 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | PD-Rx Pharmaceuticals, Inc. | 20251017 | 13 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Apotex Corp. | Apotex Inc. | 20250919 | 26 |
| LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Golden State Medical Supply, Inc. | 20250812 | 1 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Apotex Corp. | Apotex Inc. | 20250617 | 11 |
| These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20250531 | 1 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 2004 | Macleods Pharmaceuticals Limited | 20250303 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Coupler LLC | Strides Pharma Science Limited | 20250206 | 1 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 20250109 | 3 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20250109 | 5 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE Tablets Initial U.S. Approval: 1995 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20250109 | 8 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | American Health Packaging | 20240916 | 2 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral use EPIVIR (lamivudine) oral solution Initial U.S. Approval: 1995 | ViiV Healthcare Company | 20240815 | 23 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | ViiV Healthcare Company | 20240708 | 30 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Aurobindo Pharma Limited | 20240524 | 6 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | 20240519 | 7 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20240507 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Aurobindo Pharma Limited | 20240429 | 9 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Aurobindo Pharma Limited | 20240416 | 11 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Rising Pharma Holdings, Inc. | Aurobindo Pharma Limited | 20240416 | 9 |
| These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Bryant Ranch Prepack | 20240405 | 102 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20240103 | 15 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20231115 | 2 |
| These highlights do not include all the information needed to use ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS. ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 2000 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20231031 | 16 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20231030 | 14 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine tablets), for oral use Initial U.S. Approval: 1997 | ViiV Healthcare Company | 20230822 | 22 |
| These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Macleods Pharmaceuticals Limited | 20230713 | 4 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets USP, for oral use Initial U.S. Approval: 1997 | Bryant Ranch Prepack | 20230329 | 5 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | XLCare Pharmaceuticals, Inc | Ascent pharmaceuticals, Inc | 20230116 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Macleods Pharmaceuticals Limited | 20221201 | 4 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | Hetero Labs Limited Unit III | 20220916 | 7 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:2004 | Cipla USA Inc. | Cipla Ltd. Patalganga unit II | 20220118 | 8 |
| These highlights do not include all the information needed to use CIMDUO safely and effectively. See full prescribing information for CIMDUO . CIMDUO ® (lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Viatris Specialty LLC | 20210215 | 5 |
| These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Viatris Specialty LLC | 20191015 | 6 |
| These highlights do not include all the information needed to use lamivudine and zidovudine safely and effectively. See full prescribing information for lamivudine and zidovudine. Lamivudine and Zidovudine Tablets, USP Initial U.S. Approval: 1997 | Exelan Pharmaceuticals Inc. | Ascent Pharmaceuticals Inc. | 20190101 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets for Oral use. Initial U.S. Approval: 1995 | Ingenus Pharmaceuticals, LLC | Arise Pharmaceuticals LLC | Appco Pharma LLC | 20181224 | 5 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets safely and effectively. See full prescribing information for lamivudine and zidovudine tablets. lamivudine and zidovudine tablets Initial U.S. Approval: 1997 | Shanghai Desano Bio-Pharmaceutical Co., Ltd. | 20180518 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Centaur Pharmaceuticals Private Limited | 20170622 | 4 |
| Lamivudine Zidovudine | Direct Rx | 20160622 | 2 |
| These highlights do not include all the information needed to use LAMIVUDINE Oral Solution, USP safely and effectively. See full prescribing information for LAMIVUDINE Oral Solution, USP LAMIVUDINE Oral Solution, USP for oral use Initial U.S. Approval: 1995 | Marlex Pharmaceuticals Inc | 20160131 | 1 |
| These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000 | State of Florida DOH Central Pharmacy | 20140424 | 2 |
| These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 1995 | State of Florida DOH Central Pharmacy | 20140303 | 1 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | State of Florida DOH Central Pharmacy | 20140227 | 1 |
| These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets 150 mg and 300 mg, for oral use Initial U.S. Approval: 1995 | State of Florida DOH Central Pharmacy | 20130912 | 1 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | H.J. Harkins Company, Inc. | 20120625 | 1 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | Rebel Distributors Corp | 20120404 | 1 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | H.J. Harkins Company, Inc. | 20120202 | 1 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | Rebel Distributors Corp | 20100924 | 1 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | Rebel Distributors Corp | 20100924 | 1 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | Physicians Total Care, Inc. | 20100701 | 1 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | State of Florida DOH Central Pharmacy | 20100511 | 2 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | Physicians Total Care, Inc. | 20100414 | 1 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | State of Florida DOH Central Pharmacy | 20100413 | 1 |
| COMBIVIR (lamivudine and zidovudine) tablet, film coated | Stat Rx USA | 20091027 | 1 |